ROSUVASTATIN vs ROZANOLIXIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROSUVASTATIN vs ROZANOLIXIZUMAB: Safety Overview
| Metric | ROSUVASTATIN | ROZANOLIXIZUMAB |
|---|---|---|
| Total FAERS Reports | 36,332 | 303 |
| Deaths Reported | 1,536 | 9 |
| Death Rate | 4.2% | 3.0% |
| Hospitalizations | 11,195 | 114 |
| Average Patient Age | 66.1 yrs | 61.3 yrs |
| % Female Patients | 54.9% | 60.9% |
| FDA Approval Date | Apr 1, 2020 | N/A |
| Manufacturer | Umedica Laboratories USA Inc. | UCB, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |